FLORHAM PARK, N.J., Aug. 5, 2025 /PRNewswire/ -- Following last week's update from President Trump reinforcing the May 12, 2025 Executive Order Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, pharmaceutical manufacturers are now expected to implement direct-to-consumer (DTC) solutions within 60 days.
ASPN is already delivering.
As a long-standing leader in digital pharmacy services, ASPN has been live with multiple manufacturer partners for months, supporting a wide range of prescription products with fully operational DTC infrastructure. We are proud to offer a proven, turn-key solution that is not only live today—but also fully deployable for new partners within the federal 60-day timeline.
Why Manufacturers Choose ASPN:
- Live and Scalable: Supporting DTC programs for many branded pharmaceutical products
- 60-Day Deployment: Rapid implementation that meets government timelines
- Turn-Key Integration: Seamlessly connects to your brand's digital ecosystem
- Full-Service Infrastructure: Eligibility, benefits verification, pharmacy triage, and fulfillment coordination
- Flexible Pricing Models: Supports both covered benefit and direct-pay options
- Product Versatility: Retail, specialty, specialty-lite, and pipeline products
"While others are just getting started, ASPN's DTC infrastructure is live, proven, and rapidly scalable," said Asembia Co-Founder and CEO Lawrence Irene. "We're helping manufacturers meet the 60-day requirement not from scratch, but by simply turning on a solution that already exists."
To discuss how ASPN can help your organization stand up a compliant, consumer-ready DTC channel in weeks, contact us or submit your inquiry here: https://forms.uniqo.de/2ahYRW
Media Contact:
Bill Fitzgerald
Vice President, Marketing
[email protected]
SOURCE Asembia

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

Newsrooms &
Influencers

Digital Media
Outlets

Journalists
Opted In
Share this article